These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 24829369

  • 1. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T, Hasegawa T, Morita Y, Yamada N, Funada A, Takahama H, Amaki M, Kanzaki H, Okamura H, Kamakura S, Shimizu W, Anzai T, Kitakaze M.
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E, Kimura F, Nakajima T, Hiroe M, Kasai Y, Nagata M, Kawana M, Hagiwara N.
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [Abstract] [Full Text] [Related]

  • 4. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, Emdin M, Lombardi M.
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging.
    Renz DM, Röttgen R, Habedank D, Wagner M, Böttcher J, Pfeil A, Dietz R, Kivelitz D, Elgeti T.
    Rofo; 2011 Sep; 183(9):834-41. PubMed ID: 21830182
    [Abstract] [Full Text] [Related]

  • 9. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
    Smedema JP, van Geuns RJ, Ector J, Heidbuchel H, Ainslie G, Crijns HJGM.
    ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
    [Abstract] [Full Text] [Related]

  • 10. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
    Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, Fukuda K.
    Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
    Kim EK, Lee GY, Jang SY, Chang SA, Kim SM, Park SJ, Choi JO, Park SW, Choe YH, Lee SC, Oh JK.
    Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
    [Abstract] [Full Text] [Related]

  • 15. Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.
    Butler CR, Kumar A, Toma M, Thompson R, Chow K, Isaac D, Kim D, Haykowsky M, Friedrich MG, Paterson I.
    Can J Cardiol; 2013 Sep; 29(9):1076-83. PubMed ID: 23380296
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A, Kanzaki H, Noguchi T, Morita Y, Sugano Y, Ohara T, Hasegawa T, Hashimura H, Ishibashi-Ueda H, Kitakaze M, Yasuda S, Ogawa H, Anzai T.
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.
    Smith BM, Dorfman AL, Yu S, Russell MW, Agarwal PP, Mahani MG, Lu JC.
    Am J Cardiol; 2014 Apr 01; 113(7):1234-9. PubMed ID: 24513464
    [Abstract] [Full Text] [Related]

  • 18. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY, Su MY, Chen JJ, Lai LP, Hwang JJ, Tseng CD, Chen YS, Yu HY, Tseng WY, Lin JL.
    JACC Cardiovasc Imaging; 2013 Nov 01; 6(11):1152-9. PubMed ID: 24229767
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L, Symons R, Degtiarova G, Dresselaers T, Gheysens O, Wuyts W, Van Cleemput J, Bogaert J.
    Eur Radiol; 2020 Jul 01; 30(7):3702-3710. PubMed ID: 32166494
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.